Anupam Rasayan to Acquire 74.20% Stake in Bliss GVS Pharma

Anupam Rasayan India Ltd plans to acquire up to 74.20% of Bliss GVS Pharma Limited through a share purchase agreement, including an initial 43.30% stake at ₹299 per share, totaling up to ₹1369.51 Cr. The deal includes an option to acquire the remaining shares held by sellers and an open offer to public shareholders for up to 26% of the total paid-up equity share capital at ₹299 per share, aggregating to ₹829.03 Cr. The board has also approved the acquisition of 15% to 100% equity in other entities to facilitate the proposed transaction.